Fund Managers Comments

3 December 2018

Parkwalk wins ‘Best Generalist EIS Fund’ in the Investment Week 2018/19 Tax Efficiency Awards

By |December 3rd, 2018|

Parkwalk are delighted to have won ‘Best General EIS Fund’ at Investment Week’s Tax Efficiency Awards 2018 last week, beating last year’s runner’s up prize and matching our win in 2016.

Parkwalk were also highly commended in the ‘Best Exit’ category.

It is always a good validation of our investment strategy to be recognised by industry peers […]

Deal or no deal, should EIS investors be worried about Brexit?

By |December 3rd, 2018|

Given the UK’s Venture Capital Schemes (SEIS, EIS, VCT and SITR) fall under the EU State Aid rules there is the possibility that a ‘hard’ Brexit would allow the Government to loosen restrictions regarding these schemes, but it seems unlikely given the Government’s agenda.

However, under any compromise deal the UK will probably have to […]

20 November 2018

Tom Hopkins joins Parkwalk

By |November 20th, 2018|

Parkwalk are delighted to announce that Tom Hopkins has joined the team as Business Development Director. Tom has worked alongside Parkwalk since early 2015 as one of the co-founders of Kin Capital who provide fundraising services to the Parkwalk EIS Fund and will continue to do so.

Tom has 13 years’ experience across the front, […]

Parkwalk included in Global University Venturing 2018 Powerlist

By |November 12th, 2018|

Global University Venturing has just completed their inaugural Powerlist for 2018 based on their five-year data review of the university spin-out ecosystem earlier this year.

The data from the study showed Parkwalk as the world’s second most active investor in this sector, which can be seen here: Global investors in University spin-outs 2013 – 2017. Parkwalk […]

10 August 2018

Astellas announces acquisition of Quethera

By |August 10th, 2018|

Astellas Pharma Inc. and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom that is focused on developing novel treatments for ocular disorders, such as glaucoma.

Through this transaction, Astellas has acquired Quethera’s ophthalmic gene therapy program, which uses a recombinant adeno-associated viral vector system (rAAV) to introduce […]

University of Cambridge Enterprise Fund VI launched

By |August 3rd, 2018|

Parkwalk are delighted to announce the launch of the University of Cambridge Enterprise Fund VI.

Launched in conjunction with Cambridge Enterprise, the University’s Technology Transfer and academic consulting subsidiary, the University of Cambridge Enterprise Funds offer alumni and investors the opportunity to invest in companies formed to develop and commercialise technology and intellectual property developed at the University of Cambridge in […]

7 February 2018

Parkwalk wins at EISA Awards

By |February 7th, 2018|

Parkwalk are delighted to have won the ‘Best EIS Fund Manager’ category at the EISA awards on the 6th February 2018 at the House of Lords.

The award recognised an extremely strong 2017 for Parkwalk, where we committed in excess of £75m to hard-science, knowledge-intensive growth companies commercialising the best of British innovation spun-out of […]

17 July 2017

Parkwalk H1 2017 update

By |July 17th, 2017|

It has been a busy first half of the year at Parkwalk. Our proprietary access to deal-flow has enabled us to deploy £46.5m in the last 12 months. Deal-flow has been enhanced by our tie-up with IP Group plc, who recently raised a further £200m to co-invest in the university spin-out sector.

The combined group […]

2 February 2017

Parkwalk wins at EISA Awards

By |February 2nd, 2017|

Parkwalk are delighted to have won both the ‘Best Investment Exit’ and ‘Best EIS Fund Manager’ categories at the EISA awards on the 1st February 2017. The awards recognised an extremely strong 2016 for Parkwalk. They were presented at the House of Lords to firms, advisers, companies and individuals that achieved outstanding performance in the context […]

16 December 2016

Parkwalk and IP Group join forces in UK University Spin-Outs

By |December 16th, 2016|

IP Group plc acquires Parkwalk, the UK’s largest EIS growth fund manager focused on university spin-outs

IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, is delighted to announce that it has agreed to acquire Parkwalk Advisors Ltd (“Parkwalk”), the UK’s leading university spin-out focused EIS fund manager.

Founded […]

Parkwalk wins ‘Best Generalist’ in the Investment Week 2016/17 Tax Efficiency Awards

By |December 6th, 2016|

Parkwalk are delighted to have won the Investment Week ‘Best Generalist’ in their 2016/17 Tax Efficiency Awards.

 

18 July 2016

ARM Holdings – £24.3bn acquisition of the University of Cambridge spin-out

By |July 18th, 2016|

Japan’s Softbank on Monday offered £24.3bn ($32bn) in cash to acquire 100% of ARM Holdings, the UK’s smartphone chip designer that is one of the leaders in the infrastructure of the internet of things.

In 2015, Forbes ranked ARM as the most innovative company in Europe, and the fifth most innovative in the world.

The deal […]

29 June 2016

Oxford University Innovation – the new name for Isis Innovation

By |June 29th, 2016|

Isis Innovation will be renamed Oxford University Innovation, in order to enhance the already strong links between Isis Innovation and the University. This will strengthen awareness of the company and its services within the wider University, and better portray the University’s ownership of the company.
With a record 16 spinout companies launched and more than […]

Parkwalk, the EIS and Brexit

By |June 28th, 2016|

In these uncertain times post the surprise vote to leave the EU, investors are (quite rightly) focusing on macro risks and volatility.
However, as the dust begins to settle they are now looking across the fringes of their portfolios, including alternative assets such as VC and PE. As a small part of that portfolio with […]

31 March 2016

OxReach – a new philanthropic platform

By |March 31st, 2016|

We are delighted to support a new initiative from the University of Oxford, OxReach. OxReach plans to launch various projects over the next 12 months – the first of which is LIFE, who are developing ways for healthcare workers in Africa to correctly use the latest WHO care pathways in emergencies and save lives to help tackle newborn […]

22 February 2016

University of Cambridge Enterprise Fund IV launched

By |February 22nd, 2016|

Parkwalk are delighted to announce the launch of the University of Cambridge Enterprise Fund IV.

Launched in conjunction with Cambridge Enterprise, the University’s Technology Transfer and academic consulting subsidiary, the University of Cambridge Enterprise Funds offer alumni and investors the opportunity to invest in companies formed to develop and commercialise technology and intellectual property developed at the University of Cambridge in […]

Parkwalk cleans up at EISA Awards

By |February 22nd, 2016|

On February 11th 2016, Parkwalk was recognised by the judges of the EISA awards in both the ‘Best Investment Exit’ and ‘Best EIS Fund Manager’ categories. The awards recognised an extremely strong 2015 for Parkwalk. The Awards were presented at the House of Lords to firms, advisers, companies and individuals that achieved outstanding performance in […]

University of Oxford Isis Fund III launched

By |February 4th, 2016|

Parkwalk are delighted to announce the launch of the University of Oxford Isis EIS Fund III.

Launched in conjunction with Isis Innovation, the University’s Technology Transfer and academic consulting subsidiary, the University of Oxford Isis Funds offer alumni and investors the opportunity to invest in companies formed to develop and commercialise technology and intellectual property developed at the University […]

15 January 2016

University of Bristol Enterprise Fund I

By |January 15th, 2016|

Parkwalk are delighted to announce the launch of the University of Bristol Enterprise EIS Fund I.

Launched in conjunction with the University of Bristol Research and Enterprise Development Division, the University of Bristol Enterprise Funds offer alumni and investors the opportunity to invest in the development of scientific and technological innovations from the University of Bristol and from companies supported by […]

26 November 2015

Parkwalk wins Investment Week’s Investment Company of the Year award for ‘Best EIS Fund’

By |November 26th, 2015|

Parkwalk are delighted to have won the Investment Week’s Investment Company of the Year inaugural award for ‘Best EIS Fund’, following on from the Growth Investor Awards ‘Best Exit for 2015′ and the Enterprise Investment Scheme Association ‘Best EIS Exit for 2014′ and ‘Highly Commended’ Fund Manager awards in February 2015.

PARKWALK ANNOUNCED AS INVESTMENT WEEK AWARDS WINNER

Investment […]